Clinical Trial Update: Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on contralateral arytenoid sparing IMRT for T1a/T2a larynx cancer with analysis of post-treatment laryngeal function; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Neoplasms

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Laryngeal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2021-02-17